4xal: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='4xal' size='340' side='right'caption='[[4xal]], [[Resolution|resolution]] 1.87Å' scene=''> | <StructureSection load='4xal' size='340' side='right'caption='[[4xal]], [[Resolution|resolution]] 1.87Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4xal]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4xal]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_alphaherpesvirus_1_strain_17 Human alphaherpesvirus 1 strain 17]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XAL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XAL FirstGlance]. <br> | ||
</td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xal FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xal OCA], [https://pdbe.org/4xal PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xal RCSB], [https://www.ebi.ac.uk/pdbsum/4xal PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xal ProSAT]</span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/VP22_HHV11 VP22_HHV11] Tegument protein that plays different roles during the time course of infection. Participates in both the accumulation of viral mRNAs and viral protein translation at late time of infection. Modulates the RNase activity of the virion host shutoff protein UL41 probably to ensure necessary levels of key cellular mRNAs and proteins. Plays a role in microtubule reorganization that occurs after viral infection by stabilizing microtubule network. Finally, may prevent nucleosomal deposition onto the viral genome by interacting with and inhibiting host SET.<ref>PMID:12917472</ref> <ref>PMID:15795259</ref> <ref>PMID:22951838</ref> <ref>PMID:22993164</ref> <ref>PMID:24131716</ref> <ref>PMID:9658087</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 21: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Human alphaherpesvirus 1 strain 17]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Dahlroth | [[Category: Dahlroth SL]] | ||
[[Category: Hew | [[Category: Hew K]] | ||
[[Category: Nordlund | [[Category: Nordlund P]] | ||
Revision as of 21:20, 12 April 2023
Crystal structure of the conserved core domain of VP22 from HSV-1
| ||||||||||||